Last updated on March 2020

A Safety Extension Study of Ontamalimab in Participants With Moderate to Severe Ulcerative Colitis or Crohn's Disease (AIDA)


Brief description of study

The purpose of this study is to evaluate the safety and tolerability of long-term treatment with ontamalimab in participants with moderate to severe Ulcerative Colitis (UC) or Crohn's disease (CD).

Clinical Study Identifier: NCT03283085

Find a site near you

Start Over

National Clinical, LLC

Hamtramck, MI United States
8.97miles
  Connect »